`

SYLENTIS

Biotechnology Research

Specialities :
Gene sinlencing
Sirna rnai drugs
Ophtalmology
Biotechnology
Rnai

+17

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About SYLENTIS

What does Sylentis do?+

Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design. Most advanced product of the company are treatments for glaucoma and dry eye syndrome. Sylentis is a wholly owned member of PharmaMar (www.pharmamar.com)

What are Sylentis's specialties? +

Gene sinlencing,sirna rnai drugs,ophtalmology,biotechnology,rnai,r&d,pharmaceuticals,bioinformatics,biotecología,biotech,experimental drugs,glaucoma,dry eye syndrome,target therapies,production,eyes diseases,rnai clinical trials,ophthalmology,licensing,research,drug discovey,and rational design

What is Sylentis's industry? +

Sylentis operates in the Biotechnology research industry.

What is Sylentis's revenue? +

Sylentis's revenue is 11m - 100m

What is Sylentis's company size? +

Sylentis has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free